Heterozygous Familial Hypercholesterolemia (HeFH) Latest Advances
Find the Latest Research About Heterozygous Familial Hypercholesterolemia (HeFH)
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2370 publications
Obicetrapib: A Novel Cholesterol Ester Transfer Protein Inhibitor.
Journal: Cardiology in review
Published: December 23, 2025
Genetic Testing for Children with Familial Hypercholesterolemia.
Journal: Journal of atherosclerosis and thrombosis
Published: December 17, 2025
Little Evidence of Atherosclerosis in a Middle-Aged Japanese Woman with Familial Hypercholesterolemia Carrying PCSK9 (p.Glu32Lys) and ABCG8 (p.Ile419Asn) Variants Despite Elevated Lipoprotein(a) Levels.
Journal: Internal medicine (Tokyo, Japan)
Published: December 03, 2025
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 American Heart Association Scientific Sessions.
Journal: Current atherosclerosis reports
Published: December 02, 2025
Life Course Approach to Familial Hypercholesterolemia.
Journal: Current cardiology reports
Published: November 12, 2025
Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial.
Journal: JAMA
Published: November 09, 2025
Establishment of a human induced pluripotent stem cell line from a patient with familial hypercholesterolemia carrying a frameshift mutation in LDLR gene.
Journal: Stem cell research
Published: November 05, 2025
Genotype and phenotype of familial hypercholesterolemia in Egyptian children: a single-center study.
Genotype and phenotype of familial hypercholesterolemia in Egyptian children: a single-center study.
Journal: Journal of tropical pediatrics
Published: October 29, 2025
Clinical and Subclinical Atherosclerotic Disease in Adolescents With Familial Hypercholesterolemia.
Journal: JACC. Case reports
Published: October 27, 2025
Last Updated: 02/24/2026